Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 92,163 | 13,398 | 36,970 | 81,394 | 27,587 |
| Cost of Goods | N/A | N/A | 7,759 | 6,180 | 3,671 |
| Gross Profit | 92,163 | 13,398 | 29,211 | 75,214 | 23,916 |
| Operating Expenses | 97,426 | 116,910 | 135,243 | 98,329 | 81,700 |
| Operating Income | -5,263 | -103,512 | -105,273 | -22,935 | -57,113 |
| Interest Expense | 6,512 | 6,828 | 6,915 | 7,091 | 9,120 |
| Other Income | -525 | -367 | 51,680 | 10,591 | -19,244 |
| Pre-tax Income | -12,300 | -110,707 | -60,508 | -19,435 | -85,477 |
| Net Income Continuous | -12,300 | -110,707 | -60,508 | -19,435 | -85,477 |
| Net Income Discontinuous | -10,596 | 2,728 | N/A | N/A | N/A |
| Minority Interests | -380 | N/A | N/A | N/A | N/A |
| Net Income | $-22,516 | $-107,979 | $-60,508 | $-19,435 | $-85,477 |
| EPS Basic Total Ops | -0.93 | -4.49 | -2.80 | -0.90 | -4.50 |
| EPS Basic Continuous Ops | -0.49 | -4.60 | -2.75 | -0.89 | -4.35 |
| EPS Basic Discontinuous Ops | -0.44 | 0.11 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.93 | -4.49 | -2.80 | -0.90 | -4.50 |
| EPS Diluted Continuous Ops | -0.49 | -4.60 | -2.75 | -0.89 | -4.35 |
| EPS Diluted Discontinuous Ops | -0.44 | 0.11 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -0.90 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-133 | $-97,946 | $-95,976 | $-14,597 | $-47,075 |